ArticleCurrent oncology (Toronto, Ont.)2022

A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes.

Vivi Bafiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.